Role of platelet glycoprotein polymorphisms in cardiovascular diseases

Author： Meisel Christian López José Stangl Karl

ISSN： 0028-1298

Source： Naunyn-Schmiedeberg's Archives of Pharmacology, Vol.369, Iss.1, 2004-01, pp. : 38-54

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The Role of the Platelet Glycoprotein IIb / IIIa in Thrombosis and Haemostasis

Current Pharmaceutical Design, Vol. 10, Iss. 14, 2004-05 ,pp. : 1567-1576

Bentham Science Publishers

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa Receptor Antagonists: Clinical Pharmacology in Cardiovascular Diseases of Aging

By Sebastian M. Makkar R.

Drugs & Aging, Vol. 15, Iss. 3, 1999-09 ,pp. : 207-218

Adis International

Access to resources Recommend Favorite

Potential Role of Platelet Glycoprotein IIb/IIIa Antagonists in Cerebrovascular Disorders

By Mousa S.A.

CNS Drugs, Vol. 13, Iss. 3, 2000-03 ,pp. : 155-160

Adis International

Access to resources Recommend Favorite

Defining the Role of Platelet Glycoprotein Receptor Inhibitors in STEMI: Focus on Tirofiban

By Hof Arnoud W.J. van 't

Drugs, Vol. 69, Iss. 1, 2009-01 ,pp. : 85-100

Adis International

Access to resources Recommend Favorite

Renin-angiotensin system gene polymorphisms: potential mechanisms for their association with cardiovascular diseases

By Danser A.H.J. Schunkert H.

European Journal of Pharmacology, Vol. 410, Iss. 2, 2000-12 ,pp. : 303-316

Elsevier

Access to resources Recommend Favorite